Affymax, Inc. (NASDAQOTH:AFFY)
CAPS Rating:
The Company is a biopharmaceutical company developing novel peptide-based drug candidates to improve the treatment of serious and often life-threatening conditions.
The Company is a biopharmaceutical company developing novel peptide-based drug candidates to improve the treatment of serious and often life-threatening conditions.
Recs
Double top, garish sighn http://finviz.com/screener.ashx?v=211&t=MLNX,CIEN,AFFY,ATRS,BBG,BLDR,BODY,OPLK,CALL,CLDX,CYH,DMND,GDOT,HALO,INFA,KS,LNG,MDAS,MMS,NLNK,NSM,NTSP,OPLK,REXX,RPRX,SONC,SOXL,STZ,SZYM,VPHM,WG,SCG,RP,DECK,NFLX